Allurion Technologies, a weight-loss platform, launched AllurionMeds to give patients GLP-1 medications for weight loss combined with its AI-enabled Coach Iris platform.

The company aims to advance long-term weight maintenance through virtual access to dieticians and a connected smart scale that measures not just weight, but also muscle and bone mass.

Along with Coach Iris, patients will have access to glucagon-like peptide-1 (GLP-1) drugs sourced from an FDA-registered 503b facility, which means every batch has been tested for sterility and potency before release.

In a statement, the company explained that the AllurionMeds GLP-1 program, with help from Coach Iris, will address the most common concerns, such as weight regain, from patients looking to start a GLP-1 program. 

Additionally, patients in the program will have access to the Allurion connected scale and its GLP-1 companion app. The scale's measurements ensure that the quantity and quality of weight loss are being monitored.

"Feedback from patients is clear; the weight must stay off," Dr. Shantanu Gaur, founder and CEO of Allurion, said in a statement.

"Our platform was designed specifically to help patients lose weight and keep it off. AllurionMeds is built around safety, efficacy and, importantly, efficiency. Without affordable medications for weight loss and AI-powered behavior change, we risk bankrupting the US healthcare system."

THE LARGER TREND

Numerous companies have added GLP-1-focused services to their offerings.

In May, direct-to-consumer virtual care company Hims & Hers announced it would add GLP-1 medications to its offerings to assist users with weight-loss management.

New Jersey-based nutritional supplements supplier The Vitamin Shoppe launched Whole Health Rx, a telehealth service connecting users with providers to help them access GLP-1s.  

Weight-health company WeightWatchers partnered with Personify Health to allow employers using Personify to offer WeightWatchers for Business solutions, which provides programs tailored for individuals with diabetes or those on GLP-1 medications. 

In April, food and nutrition tracking app MyFitnessPal announced the launch of its GLP-1 Nutrition Plan, a set of tools and content to support members taking GLP-1s.

In January, digital weight-loss company Noom announced that its commercial business, Noom for Work, would partner with national pharmacy benefit manager Liviniti to offer plan sponsors and employees a digital GLP-1 companion.